GSK CEO Em­ma Walm­s­ley trig­gers ex­ec­u­tive team re­vamp as vac­cines chief Con­nor ex­its

GSK has more to re­port on this morn­ing than a shake­up in the on­col­o­gy pipeline. The phar­ma gi­ant tells me this morn­ing that Roger Con­nor, a 25-year vac­cine vet who’s been run­ning the di­vi­sion for the past four years, is on his way out to a new job in health­care — and they’re mak­ing some moves to in­te­grate the drugs and vac­cines ops un­der one um­brel­la in the post-con­sumer health spin­off phase.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER